Relation of melatonin to sleep architecture in children with autism

Roberta M. Leu, Liya Beyderman, Emmanuel J. Botzolakis, Kyla Surdyka, Lily Wang, Beth A. Malow

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Children with autism often suffer from sleep disturbances, and compared to age-matched controls, have decreased melatonin levels, as indicated by urine levels of the primary melatonin metabolite, 6-sulfatoxymelatonin (6-SM). We therefore investigated the relationship between 6-SM levels and sleep architecture in children with autism spectrum disorders (ASD). Twenty-three children, aged 4-10 years, completed two nights of polysomnography and one overnight urine collection for measurement of urinary 6-SM excretion rate. Parents completed the Children's Sleep Habits Questionnaire. We found that higher urinary 6-SM excretion rates were associated with increased N3 sleep, decreased N2 sleep, and decreased daytime sleepiness. The results warrant further examination to examine the effects of supplemental melatonin on sleep architecture and daytime sleepiness.

Original languageEnglish (US)
Pages (from-to)427-433
Number of pages7
JournalJournal of Autism and Developmental Disorders
Volume41
Issue number4
DOIs
StatePublished - Apr 1 2011
Externally publishedYes

Fingerprint

Melatonin
Autistic Disorder
Sleep
Urine Specimen Collection
Polysomnography
Habits
Parents
Urine
6-sulfatoxymelatonin

Keywords

  • 6-SM
  • 6-Sulfatoxymelatonin
  • Children's sleep habits questionnaire
  • Parental concerns questionnaire
  • Polysomnography
  • Sleep stages

ASJC Scopus subject areas

  • Developmental and Educational Psychology

Cite this

Relation of melatonin to sleep architecture in children with autism. / Leu, Roberta M.; Beyderman, Liya; Botzolakis, Emmanuel J.; Surdyka, Kyla; Wang, Lily; Malow, Beth A.

In: Journal of Autism and Developmental Disorders, Vol. 41, No. 4, 01.04.2011, p. 427-433.

Research output: Contribution to journalArticle

Leu, Roberta M. ; Beyderman, Liya ; Botzolakis, Emmanuel J. ; Surdyka, Kyla ; Wang, Lily ; Malow, Beth A. / Relation of melatonin to sleep architecture in children with autism. In: Journal of Autism and Developmental Disorders. 2011 ; Vol. 41, No. 4. pp. 427-433.
@article{4e70a7b9ca6b44a8b3384c6b9b71db73,
title = "Relation of melatonin to sleep architecture in children with autism",
abstract = "Children with autism often suffer from sleep disturbances, and compared to age-matched controls, have decreased melatonin levels, as indicated by urine levels of the primary melatonin metabolite, 6-sulfatoxymelatonin (6-SM). We therefore investigated the relationship between 6-SM levels and sleep architecture in children with autism spectrum disorders (ASD). Twenty-three children, aged 4-10 years, completed two nights of polysomnography and one overnight urine collection for measurement of urinary 6-SM excretion rate. Parents completed the Children's Sleep Habits Questionnaire. We found that higher urinary 6-SM excretion rates were associated with increased N3 sleep, decreased N2 sleep, and decreased daytime sleepiness. The results warrant further examination to examine the effects of supplemental melatonin on sleep architecture and daytime sleepiness.",
keywords = "6-SM, 6-Sulfatoxymelatonin, Children's sleep habits questionnaire, Parental concerns questionnaire, Polysomnography, Sleep stages",
author = "Leu, {Roberta M.} and Liya Beyderman and Botzolakis, {Emmanuel J.} and Kyla Surdyka and Lily Wang and Malow, {Beth A.}",
year = "2011",
month = "4",
day = "1",
doi = "10.1007/s10803-010-1072-1",
language = "English (US)",
volume = "41",
pages = "427--433",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Relation of melatonin to sleep architecture in children with autism

AU - Leu, Roberta M.

AU - Beyderman, Liya

AU - Botzolakis, Emmanuel J.

AU - Surdyka, Kyla

AU - Wang, Lily

AU - Malow, Beth A.

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Children with autism often suffer from sleep disturbances, and compared to age-matched controls, have decreased melatonin levels, as indicated by urine levels of the primary melatonin metabolite, 6-sulfatoxymelatonin (6-SM). We therefore investigated the relationship between 6-SM levels and sleep architecture in children with autism spectrum disorders (ASD). Twenty-three children, aged 4-10 years, completed two nights of polysomnography and one overnight urine collection for measurement of urinary 6-SM excretion rate. Parents completed the Children's Sleep Habits Questionnaire. We found that higher urinary 6-SM excretion rates were associated with increased N3 sleep, decreased N2 sleep, and decreased daytime sleepiness. The results warrant further examination to examine the effects of supplemental melatonin on sleep architecture and daytime sleepiness.

AB - Children with autism often suffer from sleep disturbances, and compared to age-matched controls, have decreased melatonin levels, as indicated by urine levels of the primary melatonin metabolite, 6-sulfatoxymelatonin (6-SM). We therefore investigated the relationship between 6-SM levels and sleep architecture in children with autism spectrum disorders (ASD). Twenty-three children, aged 4-10 years, completed two nights of polysomnography and one overnight urine collection for measurement of urinary 6-SM excretion rate. Parents completed the Children's Sleep Habits Questionnaire. We found that higher urinary 6-SM excretion rates were associated with increased N3 sleep, decreased N2 sleep, and decreased daytime sleepiness. The results warrant further examination to examine the effects of supplemental melatonin on sleep architecture and daytime sleepiness.

KW - 6-SM

KW - 6-Sulfatoxymelatonin

KW - Children's sleep habits questionnaire

KW - Parental concerns questionnaire

KW - Polysomnography

KW - Sleep stages

UR - http://www.scopus.com/inward/record.url?scp=79956048204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956048204&partnerID=8YFLogxK

U2 - 10.1007/s10803-010-1072-1

DO - 10.1007/s10803-010-1072-1

M3 - Article

C2 - 20683768

AN - SCOPUS:79956048204

VL - 41

SP - 427

EP - 433

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

SN - 0162-3257

IS - 4

ER -